Gene · 7130
Papers2,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma. | Front Oncol | 2022 | 35747790 | PubTator, text mining | PubMed |
| Bioinformatics Approach Predicts Candidate Targets for SARS-CoV-2 Infections to COPD Patients. | Biomed Res Int | 2022 | 35747501 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Facial Aesthetics: A Review. | Int J Mol Sci | 2022 | 35743181 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomic Analysis of the Mouse Pancreas: Characteristic Features of Pancreatic Ductal Cells in Chronic Pancreatitis. | Genes (Basel) | 2022 | 35741777 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell Mechanisms of Action and Clinical Effects in Osteoarthritis: A Narrative Review. | Genes (Basel) | 2022 | 35741711 | PubTator, text mining | PubMed |
| hLMSC Secretome Affects Macrophage Activity Differentially Depending on Lung-Mimetic Environments. | Cells | 2022 | 35740995 | PubTator, text mining | PubMed |
| Gene Expression-Based Functional Differences between the Bladder Body and Trigonal Urothelium in Adolescent Female Patients with Micturition Dysfunction. | Biomedicines | 2022 | 35740457 | PubTator, text mining | PubMed |
| MLBioIGE: integration and interplay of machine learning and bioinformatics approach to identify the genetic effect of SARS-COV-2 on idiopathic pulmonary fibrosis patients. | Biol Methods Protoc | 2022 | 35734766 | PubTator, text mining | PubMed |
| Implantation of a nerve protector embedded with human GMSC-derived Schwann-like cells accelerates regeneration of crush-injured rat sciatic nerves. | Stem Cell Res Ther | 2022 | 35725660 | PubTator, text mining | PubMed |
| Mesenchymal Stromal Cell Therapy in Spinal Cord Injury: Mechanisms and Prospects. | Front Cell Neurosci | 2022 | 35722621 | PubTator, text mining | PubMed |
| PCOS and Role of Cumulus Gene Expression in Assessing Oocytes Quality. | Front Endocrinol (Lausanne) | 2022 | 35721714 | PubTator, text mining | PubMed |
| Comprehensive Analyses of Ferroptosis-Related Alterations and Their Prognostic Significance in Glioblastoma. | Front Mol Biosci | 2022 | 35720126 | PubTator, text mining | PubMed |
| Present and Future Perspective on PLK1 Inhibition in Cancer Treatment. | Front Oncol | 2022 | 35719948 | PubTator, text mining | PubMed |
| Identification of Neural Progenitor Cell-associated Chemoradiotherapy Resistance Gene Set (ARL4C, MSN, TNFAIP6) for Prognosis of Glioma. | Curr Pharm Des | 2022 | 35718975 | PubTator, text mining | PubMed |
| Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19. | Stem Cell Res Ther | 2022 | 35715852 | PubTator, text mining | PubMed |
| Regulation of the Proliferation of Diabetic Vascular Endothelial Cells by Degrading Endothelial Cell Functional Genes with QKI-7. | Contrast Media Mol Imaging | 2022 | 35711530 | PubTator, text mining | PubMed |
| Advances in Stem Cell Therapies for Rotator Cuff Injuries. | Front Bioeng Biotechnol | 2022 | 35694228 | PubTator, text mining | PubMed |
| Molecular Insight into the Therapeutic Effects of Stem Cell-Derived Exosomes in Respiratory Diseases and the Potential for Pulmonary Delivery. | Int J Mol Sci | 2022 | 35682948 | PubTator, text mining | PubMed |
| Functionalized Hydrogels for Cartilage Repair: The Value of Secretome-Instructive Signaling. | Int J Mol Sci | 2022 | 35682690 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Corneal Fibrosis/Scarring. | Int J Mol Sci | 2022 | 35682600 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7130/papers?page=33